Mega Genomics Limited (HKG:6667)

Mega Genomics Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 16, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	1,633	1,615	2,505	2,449	3,110	-
Market Cap Growth	-24.60%	-35.53%	2.28%	-21.25%	-	-
Enterprise Value	1,181	1,113	2,003	1,995	2,686	-
Last Close Price	7.28	7.20	10.98	10.30	13.00	-
PE Ratio	47.80	53.71	52.26	74.01	-	-
Forward PE	-	9.77	9.77	9.77	14.29	-
PS Ratio	5.94	5.87	14.33	14.69	18.88	-
PB Ratio	2.40	2.38	3.83	3.45	4.45	-
P/TBV Ratio	2.40	2.38	3.83	3.45	4.46	-
P/FCF Ratio	-	-	41.74	17.39	-	-
P/OCF Ratio	-	-	41.19	13.58	-	-
EV/Sales Ratio	4.29	4.05	11.46	11.97	16.31	-
EV/EBITDA Ratio	29.73	28.01	32.88	51.79	-	-
EV/EBIT Ratio	39.94	37.63	39.11	67.80	-	-
EV/FCF Ratio	-	-	33.37	14.17	-	-
Debt / Equity Ratio	0.05	0.05	0.06	0.08	0.02	0.02
Debt / EBITDA Ratio	0.82	0.82	0.55	1.17	-	0.09
Debt / FCF Ratio	-	-	0.61	0.38	-	0.44
Net Debt / Equity Ratio	-0.66	-0.66	-0.75	-0.74	-0.64	-0.65
Net Debt / EBITDA Ratio	-11.38	-11.38	-8.01	-13.66	24.73	-3.85
Net Debt / FCF Ratio	-	-	-8.13	-3.74	33.36	-17.04
Asset Turnover	0.32	0.32	0.21	0.20	0.20	0.39
Inventory Turnover	5.89	5.89	9.95	15.92	18.85	22.54
Quick Ratio	3.30	3.30	6.43	5.85	7.37	9.55
Current Ratio	3.64	3.64	6.90	6.09	7.62	9.82
Return on Equity (ROE)	4.41%	4.41%	7.15%	4.76%	-2.69%	18.15%
Return on Assets (ROA)	2.11%	2.11%	3.92%	2.22%	-2.06%	11.08%
Return on Invested Capital (ROIC)	10.69%	12.13%	25.02%	11.45%	-10.52%	78.45%
Return on Capital Employed (ROCE)	4.20%	4.20%	7.40%	3.90%	-3.90%	15.50%
Earnings Yield	1.84%	1.86%	1.91%	1.35%	-0.64%	-
FCF Yield	-	-	2.40%	5.75%	-0.43%	-
Dividend Yield	2.37%	2.32%	-	-	-	-
Buyback Yield / Dilution	4.81%	4.81%	2.05%	-2.65%	-62.09%	-
Total Shareholder Return	7.17%	7.12%	2.05%	-2.65%	-62.09%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.